https://www.selleckchem.com/products/S31-201.html
his regimen remains our favoured approach to the management of localised POAML. Treatment regimens for cystic fibrosis (CF) continue to evolve and grow in complexity. Treatment regimen burden, and associated sequelae, are incompletely understood. Quality improvement (QI) methods were used to investigate treatment burden of CF care, family and care team partnerships, and potential interventions to reduce burden. Patients 6-24 years with CF and caregivers of patients 6-13 years were surveyed. Portions of validated tools and existing surve
Like
Comment
Share
